Tag: Teva

The Supreme Court’s most recent patent decision, Teva v. Sandoz (Jan. 20, 2015), establishes a hybrid standard for reviewing a district court’s claim construction. The Court specifically held that evidentiary, i.e., factual, underpinnings to claim construction are reviewed for clear …

Supreme Court Patent Scorecard Update: Teva v. Sandoz Is Patent-Neutral, But Should Impact The Claim Construction Process Read more »